Tiemin Wei

Tiemin Wei


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2020 in Stroke and Vascular Neurology
Verified
Journal Article
Open access
PDF file
YPYuesong Pan
Yuesong Pan
JJJing Jing
Jing Jing
XCXueli Cai
Xueli Cai
YWYilong Wang
Yilong Wang
SWSuying Wang
Suying Wang
YWYongjun Wang
Yongjun Wang
Background and purpose Cardiovascular diseases and dementia are two major diseases in the elderly. Atherosclerosis is associated with future vascular events and cognitive impairment. The PolyvasculaR Evaluation for Cognitive Impairment and vaScular Events (PRECISE) study is a population-based prospective cohort study with comprehensive evaluation of multiterritorial artery stenosis and plaque using advanced vascular imaging techniques and prospective collection of vascular events and cognitive assessments. Methods Between May 2017 and September 2019, the PRECISE study enrolled 3067 community-dwelling adults with ages between 50 and 75 years cluster sampled from six villages and four communities of Lishui city in China. Data are collected in face-to-face interviews at baseline, 2-year and 4-year follow-up visits. Brain MRI including high-resolution sequences for intracranial and carotidal arteries and CT angiography for thoracoabdominal arteries were performed at baseline and will be rescanned after 4 years. Cardiovascular/cerebrovascular events and cognitive assessment will be prospectively collected after the enrollment. Blood and urine samples were collected and biomarkers were tested at baseline. Results A total of 3067 subjects were enrolled, among which 53.5% were female with an average age of 61.2±6.7 years. Among them, 2.8%, 8.1%, 43.1% and 21.6% had a history of stroke, heart diseases, hypertension and diabetes mellitus, respectively. Conclusions The PRECISE study is a population-based prospective cohort study with comprehensive evaluation of atherosclerotic stenosis and plaque using advanced vascular imaging techniques. Data from this cohort provide us an opportunity to precisely evaluate polyvascular atherosclerosis and its association with future vascular events and cognitive impairment. Trial registration number ClinicalTrials.gov Registry (NCT03178448).

1 January 2015 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
WLWeixin Li
Weixin Li
MWMingchai Wu
Mingchai Wu
LTLongguang Tang
Longguang Tang
YPYong Pan
Yong Pan
ZLZhiguo Liu
Zhiguo Liu
GLGuang Liang
Guang Liang

27 June 2022 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
YPYuesong Pan
Yuesong Pan
JJJing Jing
Jing Jing
XCXueli Cai
Xueli Cai
ZJZening Jin
Zening Jin
SWSuying Wang
Suying Wang
YWYongjun Wang
Yongjun Wang
Atherosclerosis is the major underlying cause of cardiovascular disease, which is a leading cause of mortality worldwide.1 Polyvascular atherosclerosis with coexistent multiterritorial lesions was associated with a higher risk of future cardiovascular diseases.2,3 Previous studies have found that subclinical carotid atherosclerosis and coronary artery calcification increased the risk of vascular events.4,5 Approximately 7% of individuals older than 65 years were reported to have atherosclerotic renal artery stenosis, which may cause resistant hypertension and ischemic nephropathy.6,7 Other studies have shown that approximately one-third of the older community population has intracranial atherosclerosis.8 Compared with White individuals, the Asian population might have a higher prevalence of intracranial atherosclerosis, which contributes to more cases of ischemic stroke in the Asian population.9,10 Therefore, comprehensive evaluation of multiterritorial lesions is required to fully understand the distribution and burden of atherosclerosis and to precisely assess the risk of future cardiovascular and cerebrovascular events. However, previous studies either focused on individual arterial territories,8,11-13 on roughly defined polyvascular diseases according to established clinical diseases in multiple vascular territories,2 or on multiterritorial subclinical atherosclerosis without inclusion of intracranial arteries.14 There are limited data on the prevalence, vascular distribution, and burden of polyvascular atherosclerosis in the arterial system with intracranial, coronary, and peripheral vascular territories.

1 January 2005 in European Journal of Heart Failure
Verified
Journal Article
Closed access
TWTiemin Wei
Tiemin Wei
CZChunlai Zeng
Chunlai Zeng
LCLiping Chen
Liping Chen
QCQunying Chen
Qunying Chen
RZRuiying Zhao
Ruiying Zhao
LWLexin Wang
Lexin Wang
Aims: To investigate the value of B-type natriuretic peptide (BNP) in diagnosing left ventricular diastolic dysfunction in patients with hypertension. Methods: The left ventricular diastolic function and plasma BNP levels were assessed prospectively in 135 hypertensive patients. Results: The plasma BNP in patients with (n=61) and without (n=74) diastolic dysfunction was 122±105 and 18±16 pg/ml, respectively (p<0.001). Increased BNP levels were associated with systolic blood pressure (p<0.05), left ventricular mass index (p<0.001), the E/A ratio of transmitral flow (p<0.01) and the isovolumic relaxation time (p<0.01). A receiver-operator characteristic curve showing the sensitivity and specificity of BNP against the echocardiography diagnosis of diastolic dysfunction revealed an area under the curve (accuracy) of 0.904 (p40 pg/ml, the sensitivity and specificity of plasma BNP in diagnosing left ventricular diastolic dysfunction were 79% and 92%, respectively. Conclusions: The plasma BNP levels in patients with hypertension are closely related to left ventricular hypertrophy and filling impairment. Plasma BNP may be used to facilitate the diagnosis of left ventricular diastolic dysfunction.

5 March 2019 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
XCXueli Cai
Xueli Cai
LXLi-li Xia
Li-li Xia
YPYuesong Pan
Yuesong Pan
DHDian He
Dian He
HZHuiping Zhu
Huiping Zhu
YHYan He
Yan He
The prevalence of diabetes and prediabetes were estimated to be 10.9% and 35.7% in the Chinese adult population, respectively, and the middle-aged and elderly Chinese are at even higher risk of diabetes and prediabetes than younger population. With the increasing trend of aging in China, the burden of diabetes and related complications will be aggravated. Through comparing the indices of insulin resistance and β-cell function between subjects with different glucose metabolic status, to analyze the differential role of insulin resistance and β-cell function in the development of prediabetes and type 2 diabetes (T2DM) in the middle-aged and elderly Chinese population. In this cross-sectional study, we enrolled 512 participants aged 50 and over. The indices of insulin resistance (homoeostasis model assessment of insulin resistance (HOMA-IR) and adipose tissue insulin resistance (Adipo-IR), and indices of β-cell function [HOMA-β), fasting C-peptide to glucose ratio (FCPRI) and postprandial C-peptide to glucose ratio (PCPRI)] were calculated. Association of insulin resistance and β-cell function with prediabetes or T2DM were evaluated by multivariate logistic regression analysis, in which potential confounding factors were adjusted. Of the 509 participants with complete information, 263 (51.7%) had normal glucose tolerance (NGT), 161 (31.6%) were in prediabetic status and 85 (16.7%) were overt T2DM. With the advancing of unfavorable glucose metabolism, the insulin resistance (HOMA-IR and Adipo-IR) and β-cell function (FCPRI, PCPRI) deteriorated (Ptrend < 0.05 for all indices). We found that increase in insulin resistance expressed by Adipo-IR and HOMA-IR is associated with increased risk of prediabetes, whereas decrease in β-cell function expressed by HOMA-β and PCPRI is associated with increased risk of T2DM. We also demonstrated that Adipo-IR was more closely associated with developing prediabetes than HOMA-IR, and PCPRI was most closely related with developing T2DM among the indices of β-cell function used in this study. Insulin resistance is the main determinant of developing prediabetes, whereas β-cell function is the main determinant of developing T2DM.

27 September 2022 in European Journal of Preventive Cardiology
Verified
Journal Article
Closed access
PDF file
XSXin Su
Xin Su
XCXueli Cai
Xueli Cai
YPYuesong Pan
Yuesong Pan
JSJingping Sun
Jingping Sun
JJJing Jing
Jing Jing
YHYan He
Yan He
Aims: High level of apolipoprotein B (Apo B) is associated with incident subclinical atherosclerosis. The present study evaluated the associations between discordant Apo B with low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), and coronary atherosclerotic burden. Methods and results: This study enrolled 3043 participants aged 50–75 years from the PolyvasculaR Evaluation for Cognitive Impairment and vaScular Events (PRECISE) study that was conducted in the community in Lishui City, China. Discordant Apo B with LDL-C and non-HDL-C were defined by residuals and medians. Coronary atherosclerotic burden was evaluated by segment involvement score (SIS) and segment stenosis score (SSS) which were determined by computed tomography angiography. We performed discordance analyses examining associations of discordant Apo B with LDL-C or non-HDL-C with the coronary atherosclerotic burden. The mean age of participants was 61.2 ± 6.7 years, 53.6% were females. Participants with discordant high Apo B relative to non-HDL-C were at higher odds of plaques [odds ratio (OR), 1.30; 95% confidence interval (CI), 1.08–1.57], SIS [common odds ratio (cOR), 1.35; 95% CI, 1.14–1.60], and SSS (cOR, 1.40; 95% CI, 1.18–1.67) compared with concordant group. However, discordantly low Apo B with non-HDL-C was associated with decreased odds of the coronary atherosclerotic plaques and its burden. Similar results were shown for discordant analyses for Apo B with LDL-C. Conclusion: Discordantly high Apo B with LDL-C and non-HDL-C were associated with an increased odds of the coronary atherosclerotic plaques and its burden. These findings highlighted the importance of Apo B for primary prevention of coronary atherosclerosis.